Susana Maria Nunes da Silva
AuthID: R-000-GYM
1
TITLE: BRCA1 VUS: A functional analysis to differentiate pathogenic from benign variants identified in clinical diagnostic panels for breast cancer
AUTHORS: Rita Adubeiro Lourenço; Miguel Lança; Octávia Monteiro Gil; Joana Cardoso; Teresa Lourenço; José Pereira Leal; António Sebastião Rodrigues; José Rueff; Susana Nunes Silva;
PUBLISHED: 2023, SOURCE: Molecular medicine reports, VOLUME: 28, ISSUE: 1
AUTHORS: Rita Adubeiro Lourenço; Miguel Lança; Octávia Monteiro Gil; Joana Cardoso; Teresa Lourenço; José Pereira Leal; António Sebastião Rodrigues; José Rueff; Susana Nunes Silva;
PUBLISHED: 2023, SOURCE: Molecular medicine reports, VOLUME: 28, ISSUE: 1
2
TITLE: BRCA1 VUS: THE LINE BETWEEN BENIGN AND PATHOGENIC CLASSIFICATION Full Text
AUTHORS: Lourenco, Rita A.; Lanca, Miguel; Gil, Octavia M.; Rodrigues, Antonio S.; Rueff, Jose; Silva, Susana N.;
PUBLISHED: 2023, SOURCE: 26th Annual Meeting of the Portuguese-Society-of-Human-Genetics (SPGH) in MEDICINE, VOLUME: 102, ISSUE: 13
AUTHORS: Lourenco, Rita A.; Lanca, Miguel; Gil, Octavia M.; Rodrigues, Antonio S.; Rueff, Jose; Silva, Susana N.;
PUBLISHED: 2023, SOURCE: 26th Annual Meeting of the Portuguese-Society-of-Human-Genetics (SPGH) in MEDICINE, VOLUME: 102, ISSUE: 13
INDEXED IN: 
WOS
WOS3
TITLE: Special Issue: Genetic Perspectives in Thyroid Cancer
AUTHORS: Silva, SN;
PUBLISHED: 2021, SOURCE: GENES, VOLUME: 12, ISSUE: 2
AUTHORS: Silva, SN;
PUBLISHED: 2021, SOURCE: GENES, VOLUME: 12, ISSUE: 2
4
TITLE: Male and female breast cancer: the two faces of the same genetic susceptibility coin Full Text
AUTHORS: Silva, SN; Gomes, BC; Andre, S; Felix, A; Rodrigues, AS; Rueff, J;
PUBLISHED: 2021, SOURCE: BREAST CANCER RESEARCH AND TREATMENT, VOLUME: 188, ISSUE: 1
AUTHORS: Silva, SN; Gomes, BC; Andre, S; Felix, A; Rodrigues, AS; Rueff, J;
PUBLISHED: 2021, SOURCE: BREAST CANCER RESEARCH AND TREATMENT, VOLUME: 188, ISSUE: 1
5
TITLE: The Effect of ACTN3 and VDR Polymorphisms on Skeletal Muscle Performance in Axial Spondyloarthropathies
AUTHORS: Pimenta, I; Mateus, H; Rodrigues Manica, S; Pinheiro Torres, R; Neto, A; Domingues, L; Crespo, CL; Sardoo, A; Machado, P; Branco, JC; Silva, SN; Pimentel Santos, FM;
PUBLISHED: 2021, SOURCE: FRONTIERS IN GENETICS, VOLUME: 12
AUTHORS: Pimenta, I; Mateus, H; Rodrigues Manica, S; Pinheiro Torres, R; Neto, A; Domingues, L; Crespo, CL; Sardoo, A; Machado, P; Branco, JC; Silva, SN; Pimentel Santos, FM;
PUBLISHED: 2021, SOURCE: FRONTIERS IN GENETICS, VOLUME: 12
6
TITLE: Micronuclei Formation upon Radioiodine Therapy for Well-Differentiated Thyroid Cancer: The Influence of DNA Repair Genes Variants
AUTHORS: Santos, LS; Gil, OM; Silva, SN; Gomes, BC; Ferreira, TC; Limbert, E; Rueff, J;
PUBLISHED: 2020, SOURCE: GENES, VOLUME: 11, ISSUE: 9
AUTHORS: Santos, LS; Gil, OM; Silva, SN; Gomes, BC; Ferreira, TC; Limbert, E; Rueff, J;
PUBLISHED: 2020, SOURCE: GENES, VOLUME: 11, ISSUE: 9
7
TITLE: The Role of Caspase Genes Polymorphisms in Genetic Susceptibility to Philadelphia-Negative Myeloproliferative Neoplasms in a Portuguese Population
AUTHORS: Azevedo, AP; Silva, SN; Reichert, A; Lima, F; Junior, E; Rueff, J;
PUBLISHED: 2019, SOURCE: PATHOLOGY & ONCOLOGY RESEARCH, VOLUME: 25, ISSUE: 3
AUTHORS: Azevedo, AP; Silva, SN; Reichert, A; Lima, F; Junior, E; Rueff, J;
PUBLISHED: 2019, SOURCE: PATHOLOGY & ONCOLOGY RESEARCH, VOLUME: 25, ISSUE: 3
8
TITLE: Thyroid Cancer: The Quest for Genetic Susceptibility Involving DNA Repair Genes Full Text
AUTHORS: Santos, LS; Gomes, BC; Bastos, HN ; Gil, OM; Azevedo, AP; Ferreira, TC; Limbert, E; Silva, SN; Rueff, J;
PUBLISHED: 2019, SOURCE: GENES, VOLUME: 10, ISSUE: 8
AUTHORS: Santos, LS; Gomes, BC; Bastos, HN ; Gil, OM; Azevedo, AP; Ferreira, TC; Limbert, E; Silva, SN; Rueff, J;
PUBLISHED: 2019, SOURCE: GENES, VOLUME: 10, ISSUE: 8
9
TITLE: Non-receptor Tyrosine Kinases Role and Significance in Hematological Malignancies
AUTHORS: Ana Azevedo; Susana Silva; José Rueff;
PUBLISHED: 2019, SOURCE: Tyrosine Kinases as Druggable Targets in Cancer
AUTHORS: Ana Azevedo; Susana Silva; José Rueff;
PUBLISHED: 2019, SOURCE: Tyrosine Kinases as Druggable Targets in Cancer
